Focus: AOP Orphan Diseases is a Vienna-based biotech specialist focused on rare disease treatments, operating as a private company with a targeted pipeline.
Profile data last refreshed 5h ago · AI intelligence enriched 3w ago
Best suited for early-career scientists or commercial professionals seeking rare disease expertise in a lean, mission-driven environment; limited scale and transparency carry execution risk.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for AOP Orphan Diseases
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from AOP Orphan Diseases's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo